News
February 21, 2013
Trellis new CEO, Dr. Stefan Ryser, will be presenting a sketch of its oncology initiatives at the Texas Life Science Venture Forum hosted in Houston, Texas
February 14, 2013
Trellis launches its Antibody Repertoire Monitoring (ARM™) patient screening program
January 21, 2013
Trellis VP of R&D, Bill Usinger, was selected to present a talk describing the results of CellSpot™ deep screening of the immune repertoire of the OMT human transgenic rat at PEGS, held in Boston April 29-30, 2013
January 15, 2013
Trellis presents new data on antibodies targeting MRSA and Strep at the annual ASM conference to be held May 19-21, 2013 in Denver
January 13, 2013
Trellis announced today that Dr. Stefan Ryser has joined Trellis as its new CEO and Board Member
